NCT01154465

Brief Summary

Central venous catheterization (CVC) in ICU is very common. It is associated with many complications. These complications are now well identified in the literature. They are primarily mechanical, infectious and thrombotic events. Many measures are taken to reduce them as the choice of insertion site, strict aseptic technique during insertion and type of catheter used. However, despite these measures, it appears that the incidence of these complications is still high. The technique of ultra-sound guided (USG) catheter insertion has shown its effectiveness in reducing complications in the general ICU population. The increase in obesity in the general population is accompanied by an increase in the obese population in the ICU (BMI \> 30 kg.m-2). Many studies have investigated the effect of obesity on morbidity and mortality in ICU. Some studies found a higher rate of catheter infections in obese patient. Moreover, insertion of central venous catheter is technically more difficult in obese patients. To the investigators knowledge there are no studies on the impact of USG central venous catheterization in obese patients in ICU. The objective of this prospective randomized controlled study is to demonstrate the superiority of USG central venous catheterization (jugular or femoral) on complications in a population of obese patients. 450 patients will be included and dispatched in two groups (jugular or femoral) according to the chosen site of catheter insertion. In both groups, patients will be randomized in the USG technique or the usual anatomical technique. The rate of complications (mechanical, thrombotic or infectious) will be the primary endpoint. Secondary endpoints will be the following: rate of catheter colonization, rate of catheter-related bacteremia, rate of failure during insertion, number of punctures, procedure timing and mortality The investigators hope to establish a benefit in the use of USG central venous catheterization in obese ICU patients and thus contribute to improve the quality of care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
264

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 1, 2010

Completed
11 months until next milestone

Study Start

First participant enrolled

May 26, 2011

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

August 21, 2018

Status Verified

August 1, 2018

Enrollment Period

7.2 years

First QC Date

June 29, 2010

Last Update Submit

August 20, 2018

Conditions

Keywords

Central venous catheterizationObeseUltrasound guidanceJugularRandomizedIntensive Care Unit

Outcome Measures

Primary Outcomes (1)

  • Rate of complications

    To compare the rate of complications (mechanical, thrombotic and infectious) of CVC posed by US-guided method vs. anatomical method on obese patients in ICU.

    Within 4 days following installation of CVC

Secondary Outcomes (6)

  • The rate of success/failure installation

    Day 1

  • The time of installation

    Day 1

  • Number of punctures

    Day 1

  • Type of complications

    Within 4 days following installation of CVC

  • Mortality

    Within 4 days following installation of CVC

  • +1 more secondary outcomes

Study Arms (2)

Anatomical guidance puncture

ACTIVE COMPARATOR

The patient is placed supine (with a slight neck extension for jugular punctures). The preparation of the CVC installation will follow the procedures for disinfection, for skin preparation of the operator, for installation of sterile fields and for local anaesthesia. The veins will be tracked by simple palpation of the carotid pulse. The puncture will be made following: * The anterior Boulanger's incision for the internal jugular vein; * When venous aspiration is obtained, the catheter is assembled according to the Seldinger method.

Procedure: Central Venous Catheter Insertion

US-guided puncture

EXPERIMENTAL

The patient is placed supine (with a slight neck extension for jugular punctures). The ultrasound probe will be isolated by a sterile protective plastic and the operator will mount a ramp on which the puncture syringe needle is placed. A sterile gel will be used in order to visualize the vein and directly puncture under ultrasound guidance following: \- The anterior Boulanger's incision for the internal jugular vein pathway;

Procedure: Central Venous Catheter InsertionDevice: Ultrasound guidance

Interventions

The preparation of the CVC installation will follow the procedures for skin preparation of the operator, installation of sterile fields and local anaesthesia. The patients' skin disinfection before catheter insertion and care will follow the protocol: * Clean the area of insertion of the catheter with a solution of 4% aqueous povidone foaming (Betadine Scrub). * Rinse with sterile water and then drying. * First application of 5% alcohol povidone-iodine (alcoholic Betadine) far beyond the area of insertion. * Second application of 5% alcoholic povidone-iodine (alcoholic Betadine) by the operator after sterile draping. After sterilisation and puncture, the Seldinger technique is employed to insert the line: a blunt guidewire is passed through the needle, and the needle is then removed.

Also known as: Betadine, Arrow®
Anatomical guidance punctureUS-guided puncture

The ultrasound probe will be isolated by a sterile protective plastic and the operator will mount a ramp on which the puncture syringe needle is placed. A sterile gel will be used in order to visualize the vein and directly puncture under ultrasound guidance following: \- The anterior Boulanger's incision for the internal jugular vein When venous aspiration is obtained, the needle can easily be removed from the ramp and the syringe to mount the catheter following Seldinger's method.

Also known as: Site~Rite ® V (C.R. Bard Inc)
US-guided puncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years.
  • BMI ≥ 30 kg/m2.
  • Patient requiring the installation of a central venous catheter (femoral).
  • Informed consent signed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire d'Amiens

Amiens, Picardie, 80000, France

Location

MeSH Terms

Conditions

Obesity

Interventions

Povidone-Iodine

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

IodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Hervé DUPONT, MD-PhD

    Centre Hospitalo-Universitaire d'Amiens

    PRINCIPAL INVESTIGATOR
  • Norair AIRAPETIAN, MD

    Centre Hospitalier Universitaire, Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2010

First Posted

July 1, 2010

Study Start

May 26, 2011

Primary Completion

August 1, 2018

Study Completion

August 1, 2018

Last Updated

August 21, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations